Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-05-12
1:57 pm
Sale
13DRegulus Therapeutics Inc.
RGLS
Growth Equity Opportunities V LLC1,945,579
9.99%
-12,636,942decrease
(-86.66%)
View
2023-05-10
09:58 am
Purchase
13GRegulus Therapeutics Inc.
RGLS
FEDERATED HERMES INC.
FHI
3,875,578
19.9%
970,752increase
(+33.42%)
View
2023-02-01
11:43 am
Sale
13GRegulus Therapeutics Inc.
RGLS
FEDERATED HERMES INC.
FHI
2,904,826
17.25%
-26,143,439decrease
(-90.00%)
View
2023-01-31
1:51 pm
Sale
13GRegulus Therapeutics Inc.
RGLS
VICTORY CAPITAL MANAGEMENT INC850,197
5.05%
-7,653,446decrease
(-90.00%)
View
2022-10-11
09:03 am
Purchase
13GRegulus Therapeutics Inc.
RGLS
FMR LLC2,195,000
14.998%
2,195,000increase
(New Position)
View
2022-05-16
2:35 pm
Purchase
13GRegulus Therapeutics Inc.
RGLS
FEDERATED HERMES INC.
FHI
29,048,265
19.9%
29,048,265increase
(New Position)
View
2022-02-14
4:33 pm
Sale
13GRegulus Therapeutics Inc.
RGLS
Point72 Asset Management L.P.2,411,577
1.6%
-3,215,436decrease
(-57.14%)
View
2022-02-14
2:30 pm
Sale
13GRegulus Therapeutics Inc.
RGLS
Altium Capital Management LP1,729,780
2.1%
-1,500,000decrease
(-46.44%)
View
2022-02-14
2:15 pm
Sale
13GRegulus Therapeutics Inc.
RGLS
EcoR1 Capital LLC2,538,970
1.7%
-1,111,110decrease
(-30.44%)
View
2022-02-14
1:05 pm
Purchase
13GRegulus Therapeutics Inc.
RGLS
BIOTECHNOLOGY VALUE FUND L P9,661,235
9.99%
2,610,771increase
(+37.03%)
View
2022-02-02
09:55 am
Unchanged
13GRegulus Therapeutics Inc.
RGLS
VICTORY CAPITAL MANAGEMENT INC8,503,643
5.83%
0
(Unchanged)
View
2022-01-04
12:37 pm
Sale
13GRegulus Therapeutics Inc.
RGLS
VICTORY CAPITAL MANAGEMENT INC8,503,643
5.83%
-15,599decrease
(-0.18%)
View
2021-12-09
2:58 pm
Purchase
13DRegulus Therapeutics Inc.
RGLS
Growth Equity Opportunities V LLC14,582,521
9.99%
12,530,067increase
(+610.49%)
View
2021-03-08
11:05 am
Purchase
13GRegulus Therapeutics Inc.
RGLS
VICTORY CAPITAL MANAGEMENT INC8,519,242
12.73%
8,519,242increase
(New Position)
View
2021-02-12
7:23 pm
Purchase
13GRegulus Therapeutics Inc.
RGLS
BIOTECHNOLOGY VALUE FUND L P7,050,464
9.99%
4,953,756increase
(+236.26%)
View
2021-02-12
5:11 pm
Unchanged
13GRegulus Therapeutics Inc.
RGLS
Altium Capital Management LP3,229,780
6.8%
0
(Unchanged)
View
2021-02-12
4:15 pm
Purchase
13GRegulus Therapeutics Inc.
RGLS
EcoR1 Capital LLC3,650,080
5.4%
1,327,436increase
(+57.15%)
View
2020-12-09
5:13 pm
Purchase
13GRegulus Therapeutics Inc.
RGLS
Point72 Asset Management L.P.5,627,013
8.5%
5,627,013increase
(New Position)
View
2020-02-14
5:19 pm
Purchase
13GRegulus Therapeutics Inc.
RGLS
BIOTECHNOLOGY VALUE FUND L P2,096,708
9.99%
1,044,768increase
(+99.32%)
View
2020-02-14
1:51 pm
Unchanged
13GRegulus Therapeutics Inc.
RGLS
Altium Capital Management LP3,229,780
9.99%
0
(Unchanged)
View
Goto 0, 1, Next